We provide you with 20 years of free, institutional-grade data for HUGE stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of HUGE. Explore the full financial landscape of HUGE stock.
| Reported Date | CIK | Ticker | Type |
|---|
FSD Pharma Inc.(NASDAQ:HUGE) 
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and neurological di...
Website: http://www.fsdpharma.com
Founded: 1998
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Share this website to your friends
The information provided in this report about HUGE stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.